Trials / Completed
CompletedNCT03302039
Three Protocols for Phenylephrine Administration in Cesarean Delivery
Three Protocols for Phenylephrine Administration for Prophylaxis Against Post-spinal Hypotension During Cesarean Delivery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 217 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The investigators will compare variable infusion of phenylephrine (at a starting rate of 0.75 mcg/Kg/min) with fixed rate (0.75 mcg/Kg/min which will stop of reactive hypertension occurred) and single shot (1.5 mcg/Kg) phenylephrine.
Detailed description
Maternal hypotension is a common complication after spinal anesthesia for cesarean delivery (CD). Phenylephrine (PE) is the most popular vasopressor for prevention of post-spinal hypotension (PSH) during CD; however, the most appropriate protocol for PE administration is still unknown. The most common PE protocols used for prophylaxis against PSH are: single shot, fixed infusion, and variable infusion. A recent study reported that a dose of 1.5 mcg/Kg is the most suitable single-shot dose for prophylaxis. Another randomized controlled trial compared four doses of PE infusion and reported that 25 mcg/Kg/min and 50 mcg/Kg/min doses were the best doses for fixed infusion with accepted incidence of both PSH as well as reactive hypertension. Using variable infusion rate of PE had been recently introduced in another study with a starting dose of 0.75 mcg/Kg/min. The variable rate infusion showed very good results regarding PSH. In this study, the investigators will compare variable infusion of PE (at a starting rate of 0.75 mcg/Kg/min) with fixed rate (0.75 mcg/Kg/min which will stop if reactive hypertension occurred) and single shot protocol (1.5 mcg/Kg).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Single shot phenylephrine | A single shot of phenylephrine (1.5 mcg/Kg) will be administrated intravenously. |
| DRUG | Fixed infusion phenylephrine. | Fixed infusion of phenylephrine will be administrated at a rate of 0.75 mcg/Kg/min |
| DRUG | Variable infusion phenylephrine. | Variable infusion of phenylephrine will be administrated at a starting rate of 0.75 mcg/Kg/min. |
| DRUG | Bupivacaine | Bupivacaine will be administrated in the subarachnoid space for spinal anesthesia. |
Timeline
- Start date
- 2017-10-06
- Primary completion
- 2018-10-01
- Completion
- 2018-10-15
- First posted
- 2017-10-04
- Last updated
- 2018-12-17
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03302039. Inclusion in this directory is not an endorsement.